Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident
National Center for Emerging and Zoonotic Infectious Diseases
Abstract
In 2014, CDC published updated guidelines for the prevention and treatment of anthrax (Hendricks KA, Wright ME, Shadomy SV, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014;20[2]. Available at http://wwwnc.cdc.gov/eid/article/20/2/13-0687_article.htm). These guidelines provided recommended best practices for the diagnosis and treatment of persons with naturally occurring or bioterrorism-related anthrax in conventional medical settings. An aerosolized release of Bacillus anthracis spores over densely populated areas could become a mass-casualty incident. To prepare for this possibility, the U.S. government has…
Citation impact
- FWCI
- 40.97
- Percentile
- 100%
- References
- 83
Authors
6- PBPrepared byCorresponding
National Center for Emerging and Zoonotic Infectious Diseases
- WAWilliam A. Bower
National Center for Emerging and Zoonotic Infectious Diseases
- KHKatherine Hendricks
National Center for Emerging and Zoonotic Infectious Diseases
- SKSatish K. Pillai
National Center for Emerging and Zoonotic Infectious Diseases
- JTJulie T. Guarnizo
National Center for Emerging and Zoonotic Infectious Diseases
Topics & keywords
- Bacillus anthracis
- Medicine
- Mass-casualty incident
- Biological warfare
- Medical emergency
- Infection control
- Anthrax vaccines
- Public health